186 related articles for article (PubMed ID: 25225968)
21. 4-Hydroxypyridazin-3(2H)-one derivatives as novel D-amino acid oxidase inhibitors.
Hondo T; Warizaya M; Niimi T; Namatame I; Yamaguchi T; Nakanishi K; Hamajima T; Harada K; Sakashita H; Matsumoto Y; Orita M; Takeuchi M
J Med Chem; 2013 May; 56(9):3582-92. PubMed ID: 23566269
[TBL] [Abstract][Full Text] [Related]
22. Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PA
Liu Z; Gu S; Zhu X; Liu M; Cao Z; Qiu P; Li S; Liu S; Song G
Eur J Med Chem; 2022 Jan; 227():113929. PubMed ID: 34700269
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.
Song MS; Kumar G; Shadrick WR; Zhou W; Jeevan T; Li Z; Slavish PJ; Fabrizio TP; Yoon SW; Webb TR; Webby RJ; White SW
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3669-74. PubMed ID: 26976575
[TBL] [Abstract][Full Text] [Related]
24. Structural and Biochemical Basis for Development of Diketo Acid Inhibitors Targeting the Cap-Snatching Endonuclease of the Ebinur Lake Virus (Order:
Kuang W; Zhang H; Cai Y; Zhang G; Deng F; Li H; Zhou Y; Wang M; Gong P; Guo Y; Hu Z
J Virol; 2022 Apr; 96(7):e0217321. PubMed ID: 35266805
[TBL] [Abstract][Full Text] [Related]
25. Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Endonuclease activity and evaluation of inhibitors.
Xing W; Barauskas O; Kirschberg T; Niedziela-Majka A; Clarke M; Birkus G; Weissburg P; Liu X; Schultz BE; Sakowicz R; Kwon H; Feng JY
PLoS One; 2017; 12(8):e0181969. PubMed ID: 28809961
[TBL] [Abstract][Full Text] [Related]
26. Dihydrodibenzothiepine: Promising hydrophobic pharmacophore in the influenza cap-dependent endonuclease inhibitor.
Taoda Y; Miyagawa M; Akiyama T; Tomita K; Hasegawa Y; Yoshida R; Noshi T; Shishido T; Kawai M
Bioorg Med Chem Lett; 2020 Nov; 30(22):127547. PubMed ID: 32927030
[TBL] [Abstract][Full Text] [Related]
27. 1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors.
Pismataro MC; Felicetti T; Bertagnin C; Nizi MG; Bonomini A; Barreca ML; Cecchetti V; Jochmans D; De Jonghe S; Neyts J; Loregian A; Tabarrini O; Massari S
Eur J Med Chem; 2021 Oct; 221():113494. PubMed ID: 33962311
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of natural flutimide and analogous fully substituted pyrazine-2,6-diones, endonuclease inhibitors of influenza virus.
Singh SB; Tomassini JE
J Org Chem; 2001 Aug; 66(16):5504-16. PubMed ID: 11485475
[TBL] [Abstract][Full Text] [Related]
29. Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.
Boyd MJ; Bandarage UK; Bennett H; Byrn RR; Davies I; Gu W; Jacobs M; Ledeboer MW; Ledford B; Leeman JR; Perola E; Wang T; Bennani Y; Clark MP; Charifson PS
Bioorg Med Chem Lett; 2015 May; 25(9):1990-4. PubMed ID: 25827523
[TBL] [Abstract][Full Text] [Related]
30. 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
Ellis DA; Blazel JK; Tran CV; Ruebsam F; Murphy DE; Li LS; Zhao J; Zhou Y; McGuire HM; Xiang AX; Webber SE; Zhao Q; Han Q; Kissinger CR; Lardy M; Gobbi A; Showalter RE; Shah AM; Tsan M; Patel RA; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
Bioorg Med Chem Lett; 2009 Nov; 19(21):6047-52. PubMed ID: 19796938
[TBL] [Abstract][Full Text] [Related]
31. Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses.
Muratore G; Mercorelli B; Goracci L; Cruciani G; Digard P; Palù G; Loregian A
Antimicrob Agents Chemother; 2012 Nov; 56(11):6009-13. PubMed ID: 22908168
[TBL] [Abstract][Full Text] [Related]
32. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents.
Zhou Y; Li LS; Dragovich PS; Murphy DE; Tran CV; Ruebsam F; Webber SE; Shah AM; Tsan M; Averill A; Showalter RE; Patel R; Han Q; Zhao Q; Hermann T; Kissinger CR; Lebrun L; Sergeeva MV
Bioorg Med Chem Lett; 2008 Feb; 18(4):1419-24. PubMed ID: 18226901
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
[TBL] [Abstract][Full Text] [Related]
34. Some 6-aza-5-substituted-2'-deoxyuridines show potent and selective inhibition of herpes simplex virus type 1 thymidine kinase.
Basnak I; Sun M; Hamor TA; Focher F; Verri A; Spadari S; Wroblowski B; Herdewijn P; Walker RT
Nucleosides Nucleotides; 1998; 17(1-3):187-206. PubMed ID: 9708347
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel 5-hydroxy-4-pyridone-3-carboxy acids as potent inhibitors of influenza Cap-dependent endonuclease.
Miyagawa M; Akiyama T; Mikamiyama-Iwata M; Hattori K; Kurihara N; Taoda Y; Takahashi-Kageyama C; Kurose N; Mikamiyama H; Suzuki N; Takaya K; Tomita K; Matsuo K; Morimoto K; Yoshida R; Shishido T; Yoshinaga T; Sato A; Kawai M
Bioorg Med Chem Lett; 2016 Oct; 26(19):4739-4742. PubMed ID: 27568084
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and structure-activity relationships of 7-substituted 3-(2, 6-dichlorophenyl)-1,6-naphthyridin-2(1H)-ones as selective inhibitors of pp60(c-src).
Thompson AM; Rewcastle GW; Boushelle SL; Hartl BG; Kraker AJ; Lu GH; Batley BL; Panek RL; Showalter HD; Denny WA
J Med Chem; 2000 Aug; 43(16):3134-47. PubMed ID: 10956222
[TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
[TBL] [Abstract][Full Text] [Related]
39. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
[TBL] [Abstract][Full Text] [Related]
40. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
